Women’s reproductive health
Research activity includes bacterial vaginosis and women infertility, with a focus on conditions affecting the female reproductive tract and associated microbiological balance.
- bacterial vaginosis
- women infertility
The clinical portfolio reflects interest in disorders linked to the vaginal environment, fertility health, and reproductive microbiome-related conditions.
Vaginal microbiome and microbial ecology
Studies address changes in vaginal microbiome composition, including the relative abundance of Lactobacillus crispatus and Lactobacillus jensenii, within the context of microbiome restoration and vaginal microbial health.
- vaginal microbiome
- Lactobacillus crispatus
- Lactobacillus jensenii
Clinical interest extends to the role of beneficial lactic acid bacteria in maintaining a stable vaginal microbial ecosystem.
Antiseptic and antimicrobial interventions
The sponsor’s trials involve chlorhexidine vaginal antisepsis and metronidazole in relation to vaginal infection management and preparation for subsequent investigational treatment.
- chlorhexidine vaginal antisepsis
- metronidazole
- vaginal infection management
This area centers on antimicrobial support for women with bacterial vaginosis and related disturbances of the vaginal flora.
Investigational live biotherapeutics
Current research includes FB301, an investigational product studied in healthy female subjects and in women with bacterial vaginosis, indicating interest in microbiome-based therapy for gynecologic conditions.
- FB301
- healthy female subjects
- microbiome-based therapy
The therapeutic focus is on restoring or supporting the vaginal microbial community through targeted biological intervention.
